Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTOLEMAIOS: Ticagrelor vs Clopidogrel in TAVI
NCT02989558Phase 3Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Dec 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ticagrelor in aortic valve stenosis (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Number of confirmed High Intensity Transient Signals (HITS). Started Dec 2016; status: completed.
02
Drugs
ticagrelor
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT02989558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02989558.